Immunotherapy for cardiovascular disease

Esther Lutgens, Dorothee Atzler, Yvonne Doering, Johan Duchene, Sabine Steffens, Christian Weber*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)3937-3946
Number of pages13
JournalEuropean Heart Journal
Volume40
Issue number48
DOIs
Publication statusPublished - 21 Dec 2019

Keywords

  • Cardiovascular disease
  • Coronary artery disease
  • Inflammation
  • Novel therapies
  • Novel targets
  • Cytokines
  • CONGESTIVE-HEART-FAILURE
  • MYOCARDIAL-INFARCTION
  • PREVENTS ATHEROSCLEROSIS
  • PROMOTES ATHEROSCLEROSIS
  • COSTIMULATORY MOLECULES
  • MACROPHAGE PHENOTYPE
  • PLATELET CHEMOKINES
  • NLRP3 INFLAMMASOME
  • BIOLOGICAL BASIS
  • DEFICIENCY

Cite this

Lutgens, E., Atzler, D., Doering, Y., Duchene, J., Steffens, S., & Weber, C. (2019). Immunotherapy for cardiovascular disease. European Heart Journal, 40(48), 3937-3946. https://doi.org/10.1093/eurheartj/ehz283